Two modifiable variables potentially explain more than half of all atrioventricular blocks
Read More »Yearly Archives: 2019
Meds for Weight Management Underutilized Among Veterans
Only 1 percent of veterans enrolled in weight management programs receive medications
Read More »May 25, 2019
We all have patients who suffer from benign prostatic hyperplasia; they are usually seniors and most all of them are on dutasteride or finasteride, both steroidal 5-alpha reductase inhibitors. A lot of these seniors also have diabetes. This week our intern Adam Chalela, B.S. Doctor of Pharmacy Candidate from the …
Read More »Optimizing Diabetes Care: A More Personalized Patient-Centered Approach
Which baseline clinical characteristics of patients with newly diagnosed diabetes lead us to providing more personalized care?
Read More »New Approval for Praluent (alirocumab): Prevention of Cardiovascular Outcomes
Expansion of the original 2015 approval makes Praluent a strong lipid-lowering candidate for patients with diabetes and other cardiovascular concerns.
Read More »The Diabetic Risks of 5-alpha Reductase Inhibitor Exposure
Targeted medications used to treat an already at-risk population could be contributing to worsening health.
Read More »Poor Glycemic Control Linked to Sarcopenia in T2DM
Correlation independent of major covariates including anthropometric factors and diabetes duration
Read More »T2DM Is Risk Factor for Liver Fibrosis Progression in NAFLD
In multivariate analysis, age, albumin concentration, T2DM independently tied to progression
Read More »Volume Overload Present in Patients on Peritoneal Dialysis
Men and those with diabetes have higher risk of volume overload; overload linked to mortality
Read More »Medication Nonadherence Common in Patients With T2DM
Urine testing shows nonadherence highest for statins in patients with type 2 diabetes
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.